Fig. 7From: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug targetThe DCCM map of (A) H-209- KRASG12C (B) PubChem-CID11968893-KRASG12C (C) SANC00905-KRASG12C (D) ZINC001458505494-KRASG12C (E) standard drug-KRASG12C complex. The X-axis and Y-axis display number of residuesBack to article page